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Background: Cyclodextrins (CDs) have been shown to improve physicochemical and biopharmaceutical
properties of drugs when low solubility and low safety limit their use in the pharmaceutical field. Recently, a new
amphiphilic peptide-substituted-β-CD, hepta-(N-acetyl-Leu-Gly-Leu)-β-CD (hepta-(N-acetyl-LGL)-β-CD), is
developed which exhibited good solubility, strong inclusion ability and an appropriate average molecular weight.
However, there is limited information available about its toxic effects. This study was designed to evaluate
cytotoxic effects of the hepta-(N-acetyl-LGL)-β-CD (50, 200, 400, and 800 μg/ml) on rat pheochromocytoma PC-12
cells.
Results: A significant reduction of cell viability with IC50 values of 1115.0 μg/ml, 762.4 μg/ml, and 464.9 μg/ml at 6,
12, and 24 h post-treatment, respectively, as well as increased lipid peroxide levels and DNA damage were observed.
Conclusions: In conclusion, hepta-(N-acetyl-Leu-Gly-Leu)-β-CD exhibit significant toxic properties at high concentrations,
probably through induction of oxidative stress and genotoxicity.
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Toxic potential, lack of efficacy, and especially low
aqueous solubility, that lead to insufficient therapeutic
concentration in physiological fluids, are main causes of
drug delivery failure for approximately 40% of current
and 90% of new drugs in the market according to bio-
pharmaceutical classification system [1]. In order to en-
hance aqueous solubility and membrane penetration of
drugs, numerous methods including prodrugs, physical
methods, and water-soluble nanocarrier systems such as
liposomes, microemulsions, and polymeric nanoparti-
cles have been provided [1,2]. One of the beneficial
techniques to improve the water solubility, bioavailabil-
ity, and stability of drug formulations is the use of* Correspondence: karimig@mums.ac.ir
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reproduction in any medium, provided the orcyclodextrins (CDs) and chemically modified ones [3-6].
CDs are hydrophilic or relatively lipophilic oligomers
that are produced by enzymatic degradation of starch.
There are three major CDs: α-CD, β-CD, and γ-CD,
which are composed of 6, 7 or 8 α -(1,4)-linked gluco-
pyranose glucose residues, respectively, arranged in a
cone-shaped, formed a hydrophilic outer surface and a
somewhat lipophilic cavity [2,7]. Because of their use as
an excipient in pharmaceuticals, many studies have
evaluated the safety of natural CDs and their deriva-
tives in several in vitro and animal models [8,9]. Geno-
toxicity test of CDs indicated that none of them are
genotoxic and mutagenic. However, exocrine acinar cell
neoplasia was observed in some studies [9]. The
hemolytic effect, one of the main disadvantages of CDs,
also was evaluated in different studies and correlated with
their effect to solubilize membrane cholesterol [10-12].
Recently, new amphiphilic β-CDs were designed bytral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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groups through ester bond formation between the carb-
oxyl group of N-acetylated residues and C-6 of β-CD [13].
In the present study, we investigated the toxicity of
hepta-(N-acetyl-Leu-Gly-Leu)-β-CD (one of the peptide-
substituted-β-CD) designed by Seyedi et al. [13] in
PC-12 cells. Furthermore, lipid peroxidation and pos-
sible DNA damage were also evaluated.
Methods
Chemicals
Hepta-(N-acetyl-LGL)-β-CD provided by Seyedi et al.
[13]; PC-12 cells purchased from Pasteur Institute,
Tehran, Iran; Dulbecco’s Modified Eagle’s Medium
(DMEM) 4.5 mg/ml glucose, 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenylterazolium bromide (MTT), penicillin,
and streptomycin from Gibco, USA; L-glutamine, fetal bo-
vine serum (FBS), trypsin, and dimethyl sulfoxide (DMSO)
from Merck, Germany; low and normal-melting tem-
perature agarose (LMA and NMA, respectively) from
Biogen, USA; ethidium bromide (EB), thiobarbituric acid
(TBA), hydrochloric acid (HCl), trichloroacetic acid (TCA),
Bicinchoninic Acid (BCA) Kit, sodium chloride (NaCl),
ethylenediaminetetracetic acid disodium salt (Na2EDTA),
tris-(hydroxymethyl)-aminomethane (Tris–HCl), sodium
N-lauroyl-sarcosinate, Triton X-100, and sodium hydroxide
(NaOH) from Sigma-Aldrich, Germany.Cell culture
PC-12 cells were cultured with DMEM (high glucose,
4.5 mg/ml glucose) which was supplemented with 10%
FBS, 2 mM of L-glutamine, 100 U/ml of penicillin and
100 μg/ml of streptomycin and maintained in a human-
ized atmosphere (90%) containing 5% CO2 at 37°C. ATCC
instructions were used to perform subculture. Throughout
the experiment, after 2–3 days at 80-90% confluency, cells
were plated on sterile poly-L-lysine coated 96-well micro-
plates (5000 cells/well) and were used 24 h later.Cell survival assay
After 24 h seeding, cells were treated with different
concentrations (50, 200, 400, and 800 μg/ml) of hepta-
(N-acetyl-LGL)-β-CD and incubated for 6, 12, and 24 h.
MTT assay was used to determine cell viability [14].
Briefly, MTT (5 mg/ml) was added to each well and
cells were cultured for 3 h at 37°C to allow the reaction
to proceed. Then, the media was removed and the
reduced formazan crystals were dissolved in 100 μl
DMSO. The absorbance of each well was read at
550 nm using a microplate reader (VICTOR™ X3 Multi-
label Plate Reader, Perkin Elmer, Finland). For each con-
centration three wells were prepared and each plate was
run in triplicate.Alkaline single cell gel electrophoresis or comet assay
Comet assay was performed as a three-layer procedure
under alkaline (pH > 13) conditions [15] with some modi-
fications. For a typical experiment, cells were seeded in ster-
ile poly-L-lysine coated 12-well plates (106 cells/well) and
incubated at 37°C in 90% humanized atmosphere, 5%
CO2 for 24 h. The cultured cells were then washed with
PBS and exposed to different concentrations of hepta-
(N-acetyl-LGL)-β-CD (50, 200 and 800 μg/ml) for 6, 12,
and 24 h. After that, cells were trypsinized, centrifuged
at 3000 g for 4 min. 50 μl of cell pellet was suspended in
300 μl LMP agarose 1%, which was dissolved in PBS,
and kept at 37°C in water bath. 150 μl of cell/agarose
mixture was spread on a conventional 26 mm × 76 mm
microscope slides precoated with 100 μl of NMP agar-
ose 1% and covered with a top layer of NMP agarose
1%. Before the LMP agarose solidified, a cover slip was
added. Subsequently, the embedded cells were placed in
a lysis solution (2.5 M NaCl, 100 mM Na2EDTA,
10 mM Tris–HCl, 1% sodium N-lauroyl-sarcosinate, 1%
Triton X-100, and 10% DMSO; pH 10) for 24 h at 4°C.
The following day, the slides were placed in a horizontal
electrophoresis tank, immersed and left in fresh cold al-
kaline electrophoresis buffer solution (300 mM NaOH,
1 mM Na2EDTA; pH > 13) for 40 min at 4°C. Electro-
phoresis was performed using the same solution for
40 min by applying an electric field of 24 V and adjusting
the current to 300 mA. Finally, the slides were washed
three times with neutralization buffer (400 mM Tris–HCl
buffer; pH 7.5). After washing with deionized water, the
slides were placed at room temperature for 48 h to dry and
then stained with 50 μl of EB (20 μg/ml). Three wells were
treated for each experimental group and each experiment
was repeated three times.
Evaluation of DNA damage
Fluorescence microscope (Eclipse TE2000, Nikon, Japan)
applying 520–550 nm excitation filter and 580 nm bar-
rier filter was used to visualize EB stained slides (magni-
fication 400×). Comet assay software project (CASP)
was applied to determine percentage of tail DNA of
each nucleoid. One hundred nucleoids for each concen-
tration (50 per slide) were analyzed for quantification of
DNA damage.
Measurement of malondialdehyde (MDA)
PC-12 cells were cultured in sterile poly-L-lysine
coated 12- well plates (106 cells/well) according to the
procedures described above and exposed to the sample
solutions (50, 200, and 800 μg/ml). The malondialde-
hyde (MDA) content, as a measure of lipid peroxida-
tion, was assayed using the protocol described by
Mihara et al. with some modifications [16]. After treat-
ment for 6, 12, and 24 h, the cells were homogenized.
Figure 1 Effects of different concentrations of hepta-(N-acetyl-LGL)-β-CD on PC-12 cells viability. Cells were incubated with different
concentrations of the CD for 6, 12, and 24 h. Cell viability was determined by MTT assay. Data were shown as mean percentage of the treated
cells ± SEM for 3 wells per group (repeated 3 times) vs. untreated cells (control) as 100% (*P < 0.05, **P < 0.01, ***P < 0.001).
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mixture was added to the homogenate, vortexed well
and incubated in boiling water for 20 min following by
centrifugation at 3000 g for 5 min at 4°C. The absorb-
ance of the resulting supernatants was then immediatelyFigure 2 DNA damage in PC-12 cells were exposed to different conce
were shown as mean percentage of tail DNA of treated cells ± SEM for 3 w
100% (**P < 0.01,***P < 0.001).measured for the levels of MDA at 530 and 550 excita-
tion and emission wavelength, respectively. Finally, the
total protein content of the samples was determined by
BCA Kit to normalize the levels of MDA. MDA levels
were expressed in nmol/mg protein.ntrations of hepta-(N-acetyl-LGL)-β-CD for 6, 12, and 24 h. Data




200 µg/ml (12 h) 200 µg/ml (24 h)
(C) 
800 µg/ml (6 h) 800 µg/ml (12 h) 800 µg/ml (24 h)
Figure 3 Representative photomicrographs of a comet assay showing genotoxic effects of hepta-(N-acetyl-LGL)-β-CD. A: the untreated
PC-12 cells (control); B and C showing DNA damage in PC-12 cells treated with 200 and 800 μg/ml concentrations respectively after 6,12, and
24 h exposure.
Figure 4 MDA contents in PC-12 cells After treatment with different concentrations of hepta-(N-acetyl-LGL)-β-CD for 6, 12, and 24 h.
Data were shown as mean MDA contents of treated cells ± SEM for 3 wells per group (repeated 3 times) vs. untreated cells (control) (*P < 0.05,
***P < 0.001). ##p < 0.01, ###p < 0.001, comparison among different incubation times.
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Figure 5 Schematic presentations of natural CD structure and
modification sites. hepta-(N-acetyl-LGL)-β-CD synthesized by
grafting peptide chains on to the primary hydroxyl group via
esterification (A). Schematic presentation of the amphiphilic
cyclodextrin used in our work (B).
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All data are expressed as mean ± SEM. One Way Analysis
of Variance (ANOVA) followed by Tukey or Bonferroni’s
post-hoc test using GraphPad InStat version 3.00 (GraphPad
Software, San Diego, California, USA) was used toFigure 6 Schematic presentation of, hepta-(N-acetyl-LGL)-β-CD interaperform statistical analysis. P value less than 0.05 was
considered to be statistically significant.
Results
Hepta-(N-acetyl-LGL)-β-CD-induced cytotoxicity
The effects on cell viability of PC-12 cells were exposed
to different concentrations of hepta-(N-acetyl-LGL)-β-CD
examined using MTT assay. Figure 1 shows that 6, 12, and
24 h cell incubation with hepta-(N-acetyl-LGL)-β-CD
induced a significant reduction of PC-12 cell viability
at 100 μg/ml and higher concentrations vs. control
(untreated cells) (p < 0.05). However, the effect was not
time-dependent. The highest percentage of cell death was
recorded when PC-12 cells incubated with the highest
concentration of the CD (800 μg/ml) for 24 h (44.24 ±
7.41% vs. control 100%).
Evaluation of DNA damage by comet assay
As shown in Figure 2, PC-12 cells incubated with differ-
ent concentrations of hepta-(N-acetyl-LGL)-β-CD exhib-
ited significantly higher DNA damage (p < 0.05) than the
control (untreated cells) but this effect was not time-
dependent. The highest DNA damage was observed at
800 μg/ml concentration for all incubation times (6 h:
15.59 ± 1.29%; 12 h: 26.74 ± 3.06%; 24 h: 30.58 ± 3.65%)
followed by 200 μg/ml for 12 h (18.37 ± 1.75%) and 24 h
(25.47 ± 2.14%) incubation (p < 0.05). Significant induc-
tion of DNA damage in PC-12 cells by hepta-(N-acetyl-
LGL)-β-CD concentrations was presented in Figure 3.
Effects of hepta-(N-acetyl-LGL)-β-CD on MDA
As shown in Figure 4, after PC-12 cells were exposed to
different concentrations of hepta-(N-acetyl-LGL)-β-CD,
changes in contents of MDA were observed. Treatment
with the CD Significantly increased MDA levels after 6 h
(0.68 ± 0.054 nmol/mg protein), 12 h (0.88 ± 0.090 nmol/
mg protein), and 24 h (0.98 ± 0.036 nmol/mg protein)ction with cell membranes.
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0.060 nmol/mg protein) and 24 h (0.67 ± 0.032 nmol/mg
protein) incubation with 200 μg/ml dose. When the CD
concentration was increased from 200 μg/ml to 800 μg/ml,
MDA levels increased in a time-dependent manner.
Discussion
In the present study, we evaluated the cytotoxic effects
of hepta-(N-acetyl-LGL)-β-CD on PC-12 cells. The most
toxic effects observed at 800 μg/ml concentration for
24 h incubation. Our results showed that the CD effects
on cell viability may be the consequence of interaction
between the CD and cellular lipids (MDA content) and
DNA content (comet assay), possibly through strongly
lipid peroxidation and DNA damage. Comet assay is a
fast, simple, sensitive and cheap technique to investigate
DNA damage in all mammalian cell types [17]. Although
genotoxicity in other in vivo and in vitro evaluations of
α, β and γ-cyclodextrin and their alternatives was negli-
gible [8,9], we showed that incubation with high doses of
hepta-(N-acetyl-LGL)-β-CD induced obvious DNA dam-
age. Malondialdehyde (MDA) is a consequence of de-
composition of certain primary and secondary lipid
peroxidation products [18]. Significant increase in the
levels of MDA indicated that hepta-(N-acetyl-LGL)-β-
CD induced oxidative damage in PC-12 cells and this
effect was time-dependent in higher doses. The ability of
CDs to destruct basic membrane and internal cell com-
ponents like solubilizing cholesterol were reported and
correlated with their cytotoxic effects (e.g. hemolytic
activity) [10-12]. These experimental observations may
be the results of CD’s structure. It was demonstrated
that the cytotoxic effects of different β-CD derivatives
depend on their ability to extract cholesterol from the
cell membranes. This activity was strongly affected by
inserting diverse substitutions on CD’s structure [19]. In
hepta-(N-acetyl-LGL)-β-CD, an amphiphilic peptide-β-
cyclodextrin, the peptide chains would make an intimate
contact with the lipid bilayer because of its phospholipid
like shape. So it can disturb membrane integrity and its
toxicity probably is a result of this interaction (Figures 5
and 6). Also it was mentioned that nanoparticles due to
their miniscule size can more easily penetrate various
biological barriers such as cell membranes when com-
pared to non-nanoparticles and this lead to toxicity;
however, there is not enough convincing reasons [20].
Conclusions
In conclusion, we revealed that new β-CD derivative,
hepta-(N-acetyl-LGL)-β-CD, is a potential cytotoxic agent.
The results showed that measurement of lipid peroxida-
tion and DNA damage contents may be simple markers
to evaluate the cytotoxicity of novel β-CD derivatives
and provide information for future studies to find asafer peptide substitution or to alter the peptide struc-
ture. However, potential safety hazards of this carrier
in pharmaceutical formulations need further in vivo
studies.
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